An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Clinical trial NCT00171210 · COMPLETED

Trial details

NCT number: NCT00171210
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transfusional Iron Overload in β-thalassemia

Start date: 2004-10-01
Primary completion: 2008-04-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.